| Prev Close | 58.66 |
| Open | 58.33 |
| Day Low/High | 57.88 / 58.75 |
| 52 Wk Low/High | 54.17 / 71.04 |
| Volume | 806.29K |
| Avg Volume | 1.62M |
Molson Coors Brewing Co. (TAP)
58.06
0.60
1.02
NYSE : Consumer Non-Durables
| Exchange | NYSE |
| Shares Outstanding | 196.19M |
| Market Cap | 12.68B |
| EPS | 5.20 |
| P/E Ratio | 13.13 |
| Div & Yield | 1.64 (2.81%) |
Latest News
Tap Into This Buying Opportunity
Molson Coors is now cheap enough and healthy enough to be a good stock to own.
Why Market Manipulation by the Fed Is a Bad Idea; A Look at Twilio: Market Recon
A shift in the way the central bank manages its balance sheet is dangerous.
The Week Ahead: Inflation, Retail Sales and 13 Key Earnings Reports to Watch
Nvidia and Coca-Cola are just two names set to report. Here's what to key in on.
Jim Cramer: Bezos, Amazon, and Next Week's Game Plan
Next week we'll be at the tail end of earnings season. It's been a blast, at least until this past week when we got some iffy news about trade.
Chart of the Day, Part 2: A Closer Look at Constellation's Big Cannabis Bet
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
Jim Cramer: Constellation Brands Continues to Look Intriguing
Even with its 12% stock decline on Wednesday, Constellation Brands is more intriguing than it was yesterday.
Real Money Goes Behind the Scenes of the Budding Cannabis Industry
In the interest of due diligence, we went and took a close look at the ground floor of the newest investment craze.
Who Hasn't Crashed the Cannabis Party Yet?
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
Tilray Is Now a Top-Tier Cannabis Play
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.
Chart of the Day, Part 2: Tilray's Deal is Tiny Compared to Canopy's
Perhaps no company has bought into the Canadian cannabis craze more than Constellation Brands.
Tilray Stock Burns Higher With Anheuser-Busch Beverage Deal
Pot stock partnerships are a gateway to gains for cannabis investors.
Big Tobacco Hasn't Killed Cannabis, This Dance Has Only Just Begun
After Altria's investment in Cronos Group, which cannabis company will be the next target?
Jim Cramer: What If Trump Tweets Xi Forced Him to Ignite the 25% Tariff Fuse?
Here are 4 stocks that can be bought into the stock cyclone that might occur if things don't go the bulls way in the Argentine.
Molson Coors Is Poised to Rally So Drink Up Responsibly
When the markets get volatile it's time to circle back to defensive stocks.
Canopy Growth and 4 Other Cannabis Stocks That Look Good Here
These stocks offer some diversification or unique features in the legal-weed space.
Down the Marijuana Rabbit Hole: 5 Companies to Consider
It's too easy to lump all cannabis-related stocks into the moniker "marijuana." Like many other sectors, there are differentiators underneath the same way we see in semiconductors or retail or even energy. As you go down the marijuana rabbit hole, ...
If You Must Trade Tilray, Use This Options Play: Market Recon
Covered calls may be the best bet -- or wait for a dip.
Experts Are High on Cannabis Stocks' 2019 Prospects
Expect more companies to join Coca-Cola, Molson Coors and Constellation Brands in checking out the market.
Aurora Cannabis Shares Surge as Coca-Cola Confirms CBD Interest
A tie-up between the two could mark the first major U.S. firm to establish a line of CBD drinks.
Coke's Flirtation with Cannabis Reaffirms What We Already Know
The latest reports about Coke looking into cannabis confirms a broader industry trend.
3 Big-Name Stocks to Consider Shorting
A brewer facing challenges, a banking giant and a retail behemoth are ripe for downside plays.
Cannabis for Traders, Cannabis for Investors: Market Recon
Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.
Mainstream Research Just Doesn't Get Canopy Growth
Moody's and Zacks aren't seeing the potential for CBD drinks or even THC drinks.
Canada's Hexo Pursues Additional JV Cannabis Deals After Molson
Hexo is pursuing joint ventures in cosmetics, health care, candy, edibles, and vape companies.
Tilray Feeds Deal-Making Speculation on Analyst Call
Tilray reported a 95% jump in second-quarter revenue to $9.7 million, ahead of the Wall Street estimate of $9 million, in its first earnings release since it went public on July 19.
From Cannabis to China: Beer Companies Chase New Growth Opportunities
Beer companies are going to greater lengths to grow.
Closing Bell: LIVE MARKETS BLOG
All three major indices closed trading in positive territory Friday.
